Novagold Resources (AMEX:NG) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.03) by 33.33 percent. This is a 33.33 percent decrease over losses of $(0.03) per share from the same period last year.
HC Wainwright & Co. Reiterates Buy on First Wave BioPharma, Maintains $18 Price Target
HC Wainwright & Co. analyst Yi Chen reiterates First Wave BioPharma (NASDAQ:FWBI) with a Buy and maintains $18 price target.